La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Ontrak Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Ontrak ha un patrimonio netto totale di $15.4M e un debito totale di $6.7M, che porta il suo rapporto debito/patrimonio netto a 43.3%. Le sue attività totali e le sue passività totali sono rispettivamente $25.3M e $9.9M.

Informazioni chiave

45.2%

Rapporto debito/patrimonio netto

US$6.97m

Debito

Indice di copertura degli interessi	n/a
Contanti	US$7.29m
Patrimonio netto	US$15.41m
Totale passività	US$9.86m
Totale attività	US$25.28m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Newsflash: Ontrak, Inc. (NASDAQ:OTRK) Analysts Have Been Trimming Their Revenue Forecasts

Aug 18

Ontrak Non-GAAP EPS of -$0.63 misses by $0.10, revenue of $3.9M misses by $0.75M

Aug 09

Ontrak CMO Robert Accordino to depart, Judith Feld to succeed

Jul 26

Is Ontrak (NASDAQ:OTRK) Using Too Much Debt?

Feb 23

Ontrak Preferred Stock: 20%+ Yield And Potential 150% Return In One Year

Jan 24

Ontrak: Why You Should Buy The Dip

Oct 21

Ontrak: Ready To Rebound

Jul 11

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $11.1M ) di OTRK superano le sue passività a breve termine ( $7.7M ).

Passività a lungo termine: Le attività a breve termine di OTRK ( $11.1M ) superano le sue passività a lungo termine ( $2.2M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: OTRK ha più liquidità del suo debito totale.

Riduzione del debito: Cinque anni fa, OTRK aveva un patrimonio netto negativo, ma ora è positivo e quindi è migliorato.

Bilancio

Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: OTRK ha meno di un anno di cash runway in base al suo attuale free cash flow.

Previsione Cash Runway: OTRK ha meno di un anno di liquidità disponibile se il flusso di cassa libero continua a ridursi ai tassi storici del 14.2 % ogni anno

Ontrak Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Ontrak, Inc. announced delayed annual 10-K filing

Ontrak, Inc. announced delayed 10-Q filing

Ontrak, Inc. Receives Non-Compliance Letter from Nasdaq

Ontrak Receives Non-Compliance Notice from Nasdaq

Ontrak Announces 1-for-6 Reverse Split Primarily Intended to Bring the Company into Compliance with Nasdaq’s Minimum Bid Price Requirement

Ontrak, Inc. announced delayed 10-Q filing

Recent updates

New major risk - Market cap size

Second quarter 2024 earnings released: US$0.19 loss per share (vs US$1.84 loss in 2Q 2023)

New major risk - Revenue and earnings growth

Ontrak, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Ontrak, Inc., Annual General Meeting, Sep 10, 2024

Ontrak, Inc. Adopts Comprehensive Healthcare Integration (CHI) Framework to Enhance Care Delivery

A Piece Of The Puzzle Missing From Ontrak, Inc.'s (NASDAQ:OTRK) Share Price

Price target decreased by 78% to US$4.00

Ontrak Launches Mental Health Digital Twin Technology, Revolutionizing Precision Mental Healthcare Delivery

Ontrak, Inc. Provides Revenue Guidance for the Quarter Ending June 30, 2024

Ontrak, Inc. to Report Q1, 2024 Results on May 14, 2024

Ontrak, Inc. Provides Revenue Guidance for the Quarter Ended March 31, 2024

Ontrak, Inc. to Report Q4, 2023 Results on Apr 16, 2024

The Market Lifts Ontrak, Inc. (NASDAQ:OTRK) Shares 206% But It Can Do More

Ontrak, Inc. announced delayed annual 10-K filing

Ontrak Health Announces the Launch of the Ontrak Advanced Engagement System, Ushering in the Next Era of Ai-Enabled Behavioral Healthcare

Investors Give Ontrak, Inc. (NASDAQ:OTRK) Shares A 33% Hiding

Price target decreased by 78% to US$4.00

No longer forecast to breakeven

Ontrak, Inc. announced delayed 10-Q filing

New major risk - Shareholder dilution

Ontrak, Inc. Reaffirms Revenue Guidance for the Year Ending December 31, 2023

New major risk - Share price stability

Ontrak, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Ontrak Health Announces Promising Results of Formal Evaluation Conducted on Ontrak WholeHealth+ Program

Ontrak, Inc. Receives Non-Compliance Letter from Nasdaq

Ontrak Health's Study of Behavioral Health Patient Reports Outcomes Reveals 53-60% Reduction in Anxiety and Depressive Symptoms

Ontrak, Inc., Annual General Meeting, Sep 28, 2023

Ontrak Receives Non-Compliance Notice from Nasdaq

First quarter 2023 earnings released: US$2.26 loss per share (vs US$4.89 loss in 1Q 2022)

New major risk - Market cap size

Ontrak Health Announces Breakthrough Increase in Behavioral Health Diagnoses

Ontrak Announces 1-for-6 Reverse Split Primarily Intended to Bring the Company into Compliance with Nasdaq’s Minimum Bid Price Requirement

Ontrak, Inc. to Report Q2, 2023 Results on Aug 09, 2023

First quarter 2023 earnings released: US$0.38 loss per share (vs US$0.81 loss in 1Q 2022)

Ontrak, Inc. Provides Revenue Guidance for the Year Ending December 31, 2023

Full year 2022 earnings released: US$2.60 loss per share (vs US$2.47 loss in FY 2021)

Ontrak, Inc. announced delayed 10-Q filing

Price target increased to US$2.50

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Ontrak, Inc. Provides Revenue Guidance for the Year Ending December 31, 2022

Ontrak, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Ontrak Receives Letter from Nasdaq Regarding Non-Compliance with Minimum Bid Price Requirement

Price target increased to US$2.50

Ontrak, Inc. Names James Messina to its Board of Directors

Ontrak, Inc. Announces Board Changes

Newsflash: Ontrak, Inc. (NASDAQ:OTRK) Analysts Have Been Trimming Their Revenue Forecasts

Consensus revenue estimates fall by 25%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Ontrak, Inc. Provides Revenue Guidance for the Year Ending December 31, 2022

Ontrak Non-GAAP EPS of -$0.63 misses by $0.10, revenue of $3.9M misses by $0.75M

Insufficient new directors

Ontrak, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Ontrak, Inc. Announces Executive Changes

Ontrak CMO Robert Accordino to depart, Judith Feld to succeed

Ontrak, Inc., Annual General Meeting, Jul 29, 2022

Ontrak, Inc. Announces Resignation of Robert Accordino as Chief Medical Officer, Effective July 29, 2022

Price target decreased to US$2.33

Ontrak, Inc. Announces Promotion of Executives

Ontrak, Inc. Announces Board Changes

Ontrak, Inc. Provides Revenue Guidance for the Year Ending December 31, 2022

Ontrak, Inc. announced delayed annual 10-K filing

Consensus revenue estimates fall by 47%

Consensus revenue estimates fall by 47%

Ontrak, Inc. Provides Revenue Guidance for the Full Year Ending December 31, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

Ontrak, Inc. to Report Q4, 2021 Results on Mar 08, 2022

Is Ontrak (NASDAQ:OTRK) Using Too Much Debt?

Ontrak, Inc. Announces Management Resignations